Screener
Upstream Bio, Inc. UPB Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $773K-17.5% | $1.03M+82.7% | $668K+9.0% | $683K+12.5% | $937K+83.7% | ||
| $36.09M-4.7% | $36.57M+41.7% | $40.17M+84.5% | $32.98M+114% | $37.87M+169% | ||
| $7.05M-4.9% | $8.08M+19.2% | $6.67M+29.2% | $5.54M+36.3% | $7.42M+86.4% | ||
| $43.14M-4.7% | $44.65M+37.0% | $46.84M+73.9% | $38.52M+97.5% | $45.28M+151% | ||
| -$42.37M+4.5% | -$43.62M-36.2% | -$46.17M-75.4% | -$37.83M-100% | -$44.35M-153% | ||
| -5,481%-748pp | -4,218.1%+1,438pp | -6,911.2%-2,618pp | -5,539.4%-2,427pp | -4,732.9%-1,294pp | ||
| $2.67M-39.1% | $3.02M-36.2% | $3.71M-27.0% | $4.09M+40.8% | $4.38M+53.1% | ||
| -$39.7M+0.7% | -$40.59M-48.8% | -$42.46M-99.9% | -$33.75M-111% | -$39.97M-172% | ||
| -5,136.1%-871pp | -3,925.6%+892pp | -6,356.1%-2,891pp | -4,941.1%-2,307pp | -4,265.3%-1,387pp | ||
| -$0.73+1.4% | -$0.75-47.1% | -$0.78— | -$0.63+90.9% | -$0.74+88.6% | ||
| -$42.32M+4.5% | -$43.57M-36.3% | -$46.11M-75.5% | -$37.79M-100% | -$44.31M-153% | ||
| -5,474.5%-746pp | -4,213.3%+1,435pp | -6,902.7%-2,617pp | -5,532.7%-2,422pp | -4,728.4%-1,292pp | ||
| -$42.37M+4.5% | -$43.62M-36.2% | -$46.17M-75.4% | -$37.83M-100% | -$44.35M-153% |
FAQ
- What is Upstream Bio, Inc.'s revenue?
- Upstream Bio, Inc. (UPB) generated $3.2M in revenue over the trailing twelve months, up 16.0% year over year.
- Is Upstream Bio, Inc. profitable?
- Upstream Bio, Inc. is not currently profitable: it reported a net loss of $156.5M over the trailing twelve months, a -4955.7% net margin.
- What is Upstream Bio, Inc.'s earnings per share?
- Upstream Bio, Inc.'s diluted EPS over the trailing twelve months is $-2.89.
- Where does Upstream Bio, Inc.'s income statement data come from?
- Every line is extracted from Upstream Bio, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
